Skip to content

Acupuncture combined with acupoint herbal patching for persistent cough after lung cancer surgery: A non-randomised controlled trial

Acupuncture combined with acupoint herbal patching for persistent cough after lung cancer surgery: A non-randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001929
Enrollment
Unknown
Registered
2025-10-15
Start date
2021-07-15
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

The control group:Codeine phosphate tablets
The treatment group:Acupuncture and acupoint herbal patching in addition to the oral medication

Sponsors

North China Petroleum Bureau General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1)Aged =18 and =80 years old. 2)Outpatient diagnosed with stage I lung cancer through pathological diagnosis. 3)Cough symptoms last for 8 weeks or with no significant improvement after 3 weeks of conventional treatment. 4)Be willing and able to complete acupuncture and acupoint herbal patching treatment. Education level of at least primary school with normal cognitive and comprehension abilities and able to complete the required assessments. 5)Signed written informed consent form.

Exclusion criteria

Exclusion criteria: 1)Allergy to the drugs or components used in the study. 2)Local skin abrasion or ulceration at the treatment areas. 3)With other chronic respiratory diseases such as chronic bronchitis emphysema pulmonary heart disease pulmonary fibrosis or respiratory failure. 4)With a clear cause of cough including upper respiratory infection syndrome gastroesophageal reflux syndrome eosinophilic bronchitis cough-variant asthma medication reactions pulmonary or tracheal tuberculosis or adult pertussis. 5)Pregnant or lactating women. 6)With severe primary diseases in the heart liver kidney or hematopoietic system.

Design outcomes

Primary

MeasureTime frame
Cough Symptom Score;Leicester Cough Questionnaire in Mandarin-Chinese (LCQ-MC);

Secondary

MeasureTime frame
Visual Analog Scale (VAS);Adverse events;Chinese Medicine Syndrome Score;

Countries

China

Contacts

Public ContactHao Wang

North China Petroleum Bureau General Hospital

wanghaoa1308@126.com18931748821

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026